During the past decade, Clinique Sud Luxembourg conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Sud Luxembourg" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 2 trials sponsored, "Dompé Farmaceutici S.p.A" with 2 trials sponsored, "The Lymphoma Academic Research Organisation" with 2 trials sponsored and "AZ-VUB" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Sud Luxembourg" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Sud Luxembourg" are "Breast Cancer" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Diffuse Large B-cell Lymphoma" (2 trials), "Atrial Arrhythmia" (1 trials) and "Brady Tachy Syndrome" (1 trials). Many other conditions were trialed in "Clinique Sud Luxembourg" in a lesser frequency.

Most popular intervention types in "Clinique Sud Luxembourg" are "Drug" (19 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Rituximab" (3 trials), "Cyclophosphamide" (2 trials), "Ladarixin" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Sud Luxembourg" are 19 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Sud Luxembourg". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Clinique Sud Luxembourg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Sud Luxembourg, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".